| abstract |
New thiomolybdate derivatives are disclosed, their preparation, pharmaceutical compositions containing them, and methods for using these derivatives to treat diseases associated with erroneous vascularization, copper metabolism disorders, neurodegenerative disorders, obesity or NF? B dysregulation. Methods are further described to utilize pharmaceutical preparations of the thiomolybdate derivatives to treat diseases associated with erroneous vascularization, copper metabolism disorders, neurodegenerative disorders, obesity or NF? B dysregulation. |